FDA poised to approve a new drug for ALS
The FDA is expected to approve a new ALS drug by the end of September 2022.
Up Next
ALS: what to expect
Device uses brain signals to help stroke patients regain hand mobility
Fda approves new drug to treat alopecia
FDA approves first ever drug that can delay onset of type 1 diabetes
What is ALS?
Slowing the progression of ALS and living your best life
FDA approves first ever over-the-counter birth control
Breast cancer drug trial yields ‘unheard-of’ survival rates
New AI technology seeks to diagnose disease through voice analysis
Spinal cord stimulation study helps paralyzed people walk again
